Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease
Clinical trial NCT01085201 · COMPLETED
Trial details
- NCT number
- NCT01085201
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2013-02-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.